Keros Therapeutics, Inc. (KROS)
14.19
-0.84
(-5.59%)
USD |
NASDAQ |
Feb 27, 16:00
14.19
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Research and Development Expense (TTM) : 157.36M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 135.84M |
| MannKind Corp. | 66.35M |
| Sarepta Therapeutics, Inc. | 1.516B |
| Insmed, Inc. | 771.09M |
| Ionis Pharmaceuticals, Inc. | 914.12M |